BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 23077781)

  • 21. Localized and persistent erythema nodosum leprosum - a rare variant?
    Prabhu S; Rao R; Sripathi H; Rao L; Singh R
    Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of lepromatous leprosy after WHO/MDT with rapid bacterial growth.
    Oliveira ML; Pierro AP; Silveira PA; Campos MM; Vilela MF
    Lepr Rev; 2002 Dec; 73(4):386-8. PubMed ID: 12549846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
    Benard G; Sakai-Valente NY; Bianconcini Trindade MA
    Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythema nodosum leprosum in a case of histoid leprosy.
    Kaur S; Dhar S; Sharma VK; Ray R
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):292-3. PubMed ID: 8371037
    [No Abstract]   [Full Text] [Related]  

  • 25. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculonecrotic reactions in leprosy.
    Fogagnolo L; de Souza EM; Cintra ML; Velho PE
    Braz J Infect Dis; 2007 Jun; 11(3):378-82. PubMed ID: 17684644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
    Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
    Gunawan H; Yogya Y; Hafinah R; Marsella R; Ermawaty D; Suwarsa O
    Int J Mycobacteriol; 2018; 7(1):97-100. PubMed ID: 29516895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous lepromas as leprosy-type presentation.
    Alvarez-Ruiz SB; Delgado-Jiménez Y; Aragüés M; Fraga J; García-Díez A
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):344-5. PubMed ID: 16503904
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythema nodosum leprosum in histoid leprosy: a case report.
    Kumar V; Mendiratta V; Sharma RC; Kakar N; Bajaj P
    J Dermatol; 1997 Sep; 24(9):611-4. PubMed ID: 9350110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
    Kar HK; Raina A; Sharma PK; Bhardwaj M
    Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythema nodosum leprosum and HIV infection: A therapeutic experience.
    Sharma NL; Mahajan VK; Sharma VC; Sarin S; Sharma RC
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):189-93. PubMed ID: 16830640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
    Bhargava P; Kuldeep CM; Mathur NK
    Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
    [No Abstract]   [Full Text] [Related]  

  • 34. Rare atypical presentations in Type 2 lepra reaction: a case series.
    Vijendran P; Verma R; Vasudevan B; Mitra D; Badad A; Neema S
    Int J Dermatol; 2014 Mar; 53(3):323-6. PubMed ID: 24134145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon.
    Bakshi N; Rao S; Batra R
    Am J Dermatopathol; 2017 Nov; 39(11):857-859. PubMed ID: 28763338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
    Pathania V; Oberoi B; Baveja S; Shelly D; Venugopal R; Shankar P
    Int J Mycobacteriol; 2019; 8(2):208-210. PubMed ID: 31210170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S; Vaccaro SA; Rea TH; Ochoa MT
    J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
    Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
    Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
    [No Abstract]   [Full Text] [Related]  

  • 40. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.